Skip to content
Open access

Model-Based Normal Tissue Complication Probability Comparison Between Proton and Photon Therapies for Brain Tumors Complying With Planning Study Guidelines

Oct 2026 · Advances in Radiation Oncology · Vol 12, pp. 102216 · 0 citations · 20 references
Medicine

TL;DR

In this model-based planning comparison, PBT was associated with lower estimated NTCPs for selected endpoints compared with virtual IMRT, whereas IMRT showed advantages for alopecia, blindness, and brain necrosis.

Abstract

Purpose The benefit of proton beam therapy (PBT) for primary brain tumors compared with x-ray therapy has not been demonstrated by randomized controlled trials. We performed a model-based approach study to evaluate the potential benefit of PBT for brain tumors using the normal tissue complication probability (NTCP) models complying with the Radiotherapy Treatment plannINg study Guidelines (RATING). Methods and Materials Sixty-six patients with primary brain tumors treated with PBT were registered. We used 11 NTCP models, calculated NTCP for each adverse event, and estimated the PBT and intensity modulated radiation therapy (IMRT) plans for the entire patient population and for groups classified by pathology. Wilcoxon signed-rank tests were performed for statistically significant differences between the 2 modalities, and a 2-tailed test was considered significant when <.05. A reduction was considered clinically meaningful when the difference in NTCP between the 2 modalities (ΔNTCP) exceeded the prespecified threshold. Results Overall, PBT reduced NTCP from the cataracts, delayed recall, memory impairment, contralateral hearing impairment, and tinnitus. Patients with meningiomas and low-grade gliomas had similar tendencies. PBT was associated with a lower excess absolute risk of secondary cancer of the central nervous system in all patients. However, NTCPs for alopecia, blindness, and brain necrosis were higher in the PBT cohort, highlighting important clinical trade-offs. Thirty-one patients (47.0%) had at least 1 ΔNTCP above the specified threshold. Conclusions In this model-based planning comparison, PBT was associated with lower estimated NTCPs for selected endpoints compared with virtual IMRT, whereas IMRT showed advantages for alopecia, blindness, and brain necrosis. PBT may offer meaningful clinical benefits, particularly in reducing the excess absolute risk of secondary cancer for patients with long-term survival. In addition, the comparison based on Radiotherapy Treatment plannINg study Guidelines made the study more objective than similar previous studies.

Read PDF

Similar papers

Open access Oct 2026

Comparison of Different Models in Calculation of Tumor Control Probability and Normal Tissue Complication Probability in Breast Cancer Radiotherapy

Background: The aim of this study is to compare tumor control probability (TCP) for the planning target volume (PTV) using Poisson, Niemierko, and Zaider-Minerbo models, and normal tissue complication probability (NTCP) for organs at risk (OARs) using Niemierko, Lyman-Kutcher-Burman (LKB) and relative seriality (RS) mo...

Hayder Tareq, Mahdi Ghorbani, M. Deevband et al. · 0 citations
Nov 2026

PROton therapy for HPV-related oroPHaryngeal cancer patients using normal tissue complication probability (NTCP) modEl-based strategy: an iTalian multIcenter retrospective Cross-sectional study - PROPHETIC.

BACKGROUND Intensity-modulated proton therapy (IMPT) has shown promise in reducing toxicityfor patients with oropharyngeal squamous cell carcinoma (OPSCC), while maintaining comparable tumor control to intensity-modulated radiation therapy (IMRT). However, technical, logistical and economic factors have limited widespr...

A. Vai, V. Pavanello, A. Camarda et al. · 0 citations
Open access Oct 2026

Feasibility study of dose calculation based on contrast-enhanced computed tomography for stereotactic body radiation therapy of lung metastases treated with MR-Linac

When clinical risks are appropriately managed, CHCT has the potential to serve as a reference image for lung tumor SBRT on MR-Linac to optimize imaging utilization and enhance clinical workflow efficiency.

Guo-Qiang Zhao, Min Liu, Ya-Xi Liu et al. · 0 citations
Open access Oct 2026

Clinical Impact of Intensity-Modulation Radiation Therapy versus 3D Conformal Radiation Therapy in Breast Cancer Patients: Toxicity and Organ Sparing

Radiotherapy selection in breast cancer depends on multiple clinical and dosimetric factors, as it influences organs at risk and determines both early and late toxicities that may affect long-term outcomes. This study compared intensity-modulated radiotherapy (IMRT) and three-dimensional conformal radiotherapy (3D-CRT)...

A. Atia · 0 citations
Open access Oct 2026

Impact of anatomical changes on simulated proton arc therapy and intensity‐modulated proton therapy for lung cancer

Abstract Purpose : During lung cancer radiotherapy, inter‐fractional anatomical changes may cause the delivered dose to deviate from the primary plan, affecting tumor control and increasing the risk of normal tissue damage. This study aims to evaluate the impact of anatomical changes on the dosimetric and radiobiologic...

Wen-Guang Chen, Feng Yang, Fan-Rui Zeng et al. · 0 citations
Oct 2026

Does a Magnetic Resonance-Only Pathway Impact Dosimetric and Acute Clinical Outcomes in Prostate Stereotactic Ablative Body Radiotherapy?

AIMS This study aimed to compare prostate target and organs at risk (OAR) volumes, doses, and acute toxicity scores for patients treated with prostate stereotactic ablative body radiotherapy (SABR) using magnetic resonance (MR)-only or MR registered with computed tomography (MR-CT) pathways. MATERIALS AND METHODS A t...

J. Wyatt, April Eassom, Serena West et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.